| |
| |
| Contributors | |
| |
| |
| |
| Fundamentals of Human Genome Epidemiology Revisited | |
| |
| |
| |
| Human Genome Epidemiology: The Road Map Revisited | |
| |
| |
| |
| |
| Principles of Analysis of Germline Genetics | |
| |
| |
| |
| |
| The Public Health Genomics Enterprise | |
| |
| |
| |
| |
| Navigating the Evolving Knowledge of Human Genetic Variation in Health and Disease | |
| |
| |
| |
| |
| Methods and Approaches for Data Collection, Analysis, and Integration | |
| |
| |
| |
| The Global Emergence of Epidemiological Biobanks: Opportunities and Challenges | |
| |
| |
| |
| |
| Case-Control and Cohort Studies in the Age of Genome-wide Associations | |
| |
| |
| |
| |
| The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities | |
| |
| |
| |
| |
| Design and Analysis Issues in Genome-wide Association Studies | |
| |
| |
| |
| |
| The Challenge of Assessing Complex Gene-Environment and Gene-Gene Interactions | |
| |
| |
| |
| |
| STrengthening the REporting of Genetic Association Studies (STREGA)-an Extension of the STROBE Statement | |
| |
| |
| |
| |
| Integration of the Evidence on Gene-Disease Associations: Methods of HuGE Reviews | |
| |
| |
| |
| |
| Genome-wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases | |
| |
| |
| |
| |
| Case Studies: Cumulative Assessment of the Role of Human Genome Variation in Specific Diseases | |
| |
| |
| |
| Colorectal Cancer | |
| |
| |
| |
| |
| Childhood Leukemias | |
| |
| |
| |
| |
| Bladder Cancer | |
| |
| |
| |
| |
| Type 2 Diabetes | |
| |
| |
| |
| |
| Osteoporosis | |
| |
| |
| |
| |
| Preterm Birth | |
| |
| |
| |
| |
| Coronary Heart Disease | |
| |
| |
| |
| |
| Schizophrenia | |
| |
| |
| |
| |
| Applications of Epidemiologic Methods for Using Genetic Information in Medicine and Public Health | |
| |
| |
| |
| Mendelian Randomization: The Contribution of Genetic Epidemiology to Elucidating Environmentally Modifiable Causes of Disease | |
| |
| |
| |
| |
| Evaluation of Predictive Genetic Tests for Common Diseases: Bridging Epidemiological Clinical and Public Health Measures | |
| |
| |
| |
| |
| The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: Methods of the EGAPP Working Group | |
| |
| |
| |
| |
| Rapid, Evidence-based Reviews of Genetic Tests | |
| |
| |
| |
| |
| Role of Social and Behavioral Research in Assessing the Utility of Genetic Information | |
| |
| |
| |
| |
| Assessing the Evidence for Clinical Utility in Newborn Screening | |
| |
| |
| |
| |
| The Role of Epidemiology in Assessing the Potential Clinical Impact of Pharmacogenomics | |
| |
| |
| |
| |
| The Human Epigenome and Cancer | |
| |
| |
| |
| |
| The Use of Family History in Public Health Practice: The Epidemiologic View | |
| |
| |
| |
| |
| Case Studies: Assessing the Use of Genetic Information in Practice for Specific Diseases | |
| |
| |
| |
| Cytochrome P450 Testing in the Treatment of Depression | |
| |
| |
| |
| |
| A Rapid-ACCE Review of CYP2C9 and VKORC1 Allele Testing to Inform Warfarin Dosing in Adults at Elevated Risk for Thrombotic Events to Avoid Serious Bleeding | |
| |
| |
| |
| |
| Hereditary Hemochromatosis: Population Screening for Gene Mutations | |
| |
| |
| |
| Index | |